Welding-related parkinsonism: clinical features, treatment, and pathophysiology
- PMID: 11148228
- DOI: 10.1212/wnl.56.1.8
Welding-related parkinsonism: clinical features, treatment, and pathophysiology
Abstract
Objective: To determine whether welding-related parkinsonism differs from idiopathic PD.
Background: Welding is considered a cause of parkinsonism, but little information is available about the clinical features exhibited by patients or whether this is a distinct disorder.
Methods: The authors performed a case-control study that compared the clinical features of 15 career welders, who were ascertained through an academic movement disorders center and compared to two control groups with idiopathic PD. One control group was ascertained sequentially to compare the frequency of clinical features, and the second control group was sex- and age-matched to compare the frequency of motor fluctuations.
Results: Welders were exposed to a mean of 47,144 welding hours. Welders had a younger age at onset (46 years) of PD compared with sequentially ascertained controls (63 years; p < 0.0001). There was no difference in frequency of tremor, bradykinesia, rigidity, asymmetric onset, postural instability, family history, clinical depression, dementia, or drug-induced psychosis between the welders and the two control groups. All treated welders responded to levodopa. Motor fluctuations and dyskinesias occurred at a similar frequency in welders and the two control groups. PET with 6-[18F]fluorodopa obtained in two of the welders showed findings typical of idiopathic PD, with greatest loss in posterior putamen.
Conclusions: Parkinsonism in welders is distinguished clinically only by age at onset, suggesting welding may be a risk factor for PD. These preliminary data cannot exclude a genetic contribution to susceptibility in these exposed individuals.
Comment in
-
Environmental toxins accelerate Parkinson's disease onset.Neurology. 2001 Jan 9;56(1):4-5. doi: 10.1212/wnl.56.1.4. Neurology. 2001. PMID: 11148226 No abstract available.
-
Welding-related parkinsonism: clinical features, treatment, and pathophysiology.Neurology. 2001 Sep 11;57(5):936; author reply 936-7. Neurology. 2001. PMID: 11552041 No abstract available.
-
Welding-related parkinsonism: clinical features, treatment, and pathophysiology.Neurology. 2001 Sep 11;57(5):936-7. Neurology. 2001. PMID: 11575307 No abstract available.
-
Welding-related parkinsonism: clinical features, treatment, and pathophysiology.Neurology. 2001 Nov 13;57(9):1738-9. doi: 10.1212/wnl.57.9.1738-a. Neurology. 2001. PMID: 11706132 No abstract available.
-
Welding and Parkinson disease: is there a bond?Neurology. 2005 Jun 28;64(12):2001-3. doi: 10.1212/wnl.64.12.2001. Neurology. 2005. PMID: 15985564 No abstract available.
Similar articles
-
Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders.Neurology. 2005 Jan 25;64(2):230-5. doi: 10.1212/01.WNL.0000149511.19487.44. Neurology. 2005. PMID: 15668418
-
Is electric arc welding linked to manganism or Parkinson's disease?Toxicol Rev. 2005;24(4):237-57. doi: 10.2165/00139709-200524040-00004. Toxicol Rev. 2005. PMID: 16499406 Review.
-
Increased risk of parkinsonism associated with welding exposure.Neurotoxicology. 2012 Oct;33(5):1356-61. doi: 10.1016/j.neuro.2012.08.011. Epub 2012 Sep 3. Neurotoxicology. 2012. PMID: 22975422 Free PMC article.
-
Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure.Neurology. 2011 Apr 12;76(15):1296-301. doi: 10.1212/WNL.0b013e3182152830. Epub 2011 Apr 6. Neurology. 2011. PMID: 21471467 Free PMC article.
-
State-of-the-science review: Does manganese exposure during welding pose a neurological risk?J Toxicol Environ Health B Crit Rev. 2007 Nov-Dec;10(6):417-65. doi: 10.1080/15287390600975004. J Toxicol Environ Health B Crit Rev. 2007. PMID: 17710609 Review.
Cited by
-
Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: attenuation of thymine base lesions by glutathione and N-acetylcysteine.Toxicol Lett. 2013 Apr 26;218(3):299-307. doi: 10.1016/j.toxlet.2012.12.024. Epub 2013 Jan 4. Toxicol Lett. 2013. PMID: 23296100 Free PMC article.
-
Age- and manganese-dependent modulation of dopaminergic phenotypes in a C. elegans DJ-1 genetic model of Parkinson's disease.Metallomics. 2015 Feb;7(2):289-98. doi: 10.1039/c4mt00292j. Metallomics. 2015. PMID: 25531510 Free PMC article.
-
Thalamic GABA predicts fine motor performance in manganese-exposed smelter workers.PLoS One. 2014 Feb 4;9(2):e88220. doi: 10.1371/journal.pone.0088220. eCollection 2014. PLoS One. 2014. PMID: 24505436 Free PMC article.
-
Manganese and Vanadium Co-Exposure Induces Severe Neurotoxicity in the Olfactory System: Relevance to Metal-Induced Parkinsonism.Int J Mol Sci. 2024 May 13;25(10):5285. doi: 10.3390/ijms25105285. Int J Mol Sci. 2024. PMID: 38791326 Free PMC article.
-
Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury.Toxicol Appl Pharmacol. 2011 Nov 1;256(3):219-26. doi: 10.1016/j.taap.2011.06.001. Epub 2011 Jun 13. Toxicol Appl Pharmacol. 2011. PMID: 21684300 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical